Skip to main content
. 2023 May 2;3(4):611–621. doi: 10.1016/j.jacasi.2023.03.005

Table 3.

Hospitalization or Mortality in HFrEF and HFpEF

Comorbidity Group HFrEF
HFpEF
No. at Risk No. of Events Unadjusted HR (95% CI) Adjusted HR (95% CI)a No. at Risk No. of Events Unadjusted HR (95% CI) Adjusted HR (95% CI)a
All-cause deaths or heart failure hospitalization at 1 y
No DM, no CKD 1,163 155 (13.3) 1.00 (Ref) 1.00 (Ref) 367 20 (5.5) 1.00 (Ref) 1.00 (Ref)
DM only 771 163 (21.1) 1.66 (1.33-2.07) 1.43 (1.14-1.80) 261 19 (7.3) 1.35 (0.72-2.53) 1.01 (0.52-1.95)
CKD only 735 170 (23.1) 1.84 (1.48-2.29) 1.43 (1.14-1.80) 248 45 (18.2) 3.62 (2.14-6.12) 2.54 (1.46-4.41)
DM+CKD 944 338 (35.8) 3.08 (2.55-3.73) 2.07 (1.68-2.55) 378 87 (23.0) 4.66 (2.87-7.58) 2.37 (1.40-4.02)
All-cause deaths or all-cause hospitalization at 1 y
No DM, no CKD 1163 302 (26.0) 1.00 (Ref) 1.00 (Ref) 367 56 (15.3) 1.00 (Ref) 1.00 (Ref)
DM only 771 255 (33.1) 1.33 (1.13-1.57) 1.19 (1.00-1.41) 261 55 (21.1) 1.42 (0.98-2.07) 1.12 (0.76-1.66)
CKD only 735 261 (35.6) 1.44 (1.22-1.70) 1.16 (0.98-1.39) 248 79 (31.9) 2.34 (1.66-3.29) 1.71 (1.19-2.45)
DM+CKD 944 456 (48.4) 2.18 (1.88-2.52) 1.58 (1.34-1.85) 378 154 (40.7) 3.20 (2.36-4.35) 1.90 (1.36-2.66)

Values are n (%), unless otherwise indicated.

HRQoL = health-related quality of life; other abbreviations as in Tables 1 and 2.

a

Adjusted for age, sex, ethnicity, enrollment type, regional income, systolic BP, heart rate, ejection fraction, coronary artery disease, chronic obstructive pulmonary disease, atrial fibrillation, peripheral arterial vascular disease, use of ACE inhibitors, ARBs, beta-blockers, and diuretics.